Cervical myelopathy is a consequence of spinal cord compression in the cervical spine. Degenerative cervical spondylosis, osteophytes, discosteophyte complex, degenerative spondylolisthesis and hypertrophy of ligamentum flavum are the main etiologies of cervical myelopathy. Metastasis to cervical spine could be a rare cause of cervical myelopathy. The present study is a case report; presented a 36-year-old male with severe pain in cervical region, gait disability and impairment in sensory and motor function of upper left extremity. The patient had a history of thyroidectomy and cervical lymph node dissection due to follicular thyroid carcinoma (FTC) with improper follow-ups. He was diagnosed with metastatic cervical myelopathy and underwent surgical treatment. Cervical myelopathy due to metastasis is a rare condition and only few cases have been reported so far. So myelopathies can be a complication of metastatic cancers, and it should be considered by health professionals.
Zhang, A.S., Myers, C., McDonald, C.L., Alsoof, D., Anderson, G. and Daniels, A.H. (2022) Cervical Myelopathy: Diagnosis, Contemporary Treatment, and Outcomes. The American Journal of Medicine, 135, 435-443. https://doi.org/10.1016/j.amjmed.2021.11.007
[3]
Nouri, A., Kato, S., Robinson, M.W., Munne, J.C.M., Yang, G., Jeong, W., et al. (2018) Friday, September 28, 2018 4:05 PM-5: 05 PM Abstracts: Cervical Myelopathy and Deformity. The Spine Journal, 18, S128. https://doi.org/10.1016/j.spinee.2018.06.524
[4]
Choi, S.H. and Kang, C.-N. (2020) Degenerative Cervical Myelopathy: Pathophysiology and Current Treatment Strategies. Asian Spine Journal, 14, 710. https://doi.org/10.31616/asj.2020.0490
[5]
Alsoof, D., Johnson, K., Kutschke, M., McDonald, C.L., Klinge, P. and Daniels, A.H. (2022) Management of Patients with Cervical Myelopathy and Normal Pressure Hydrocephalus: Epidemiology, Medical and Surgical Complications. Clinical Neurology and Neurosurgery, 218, Article ID: 107269. https://doi.org/10.1016/j.clineuro.2022.107269
[6]
Yamaguchi, S., Mitsuhara, T., Abiko, M., Takeda, M. and Kurisu, K. (2018) Epidemiology and Overview of the Clinical Spectrum of Degenerative Cervical Myelopathy. Neurosurgery Clinics, 29, 1-12. https://doi.org/10.1016/j.nec.2017.09.001
[7]
Pittas, A.G., Adler, M., Fazzari, M., Tickoo, S., Rosai, J., Larson, S.M., et al. (2000) Bone Metastases from Thyroid Carcinoma: Clinical Characteristics and Prognostic Variables in One Hundred Forty-Six Patients. Thyroid, 10, 261-268. https://doi.org/10.1089/thy.2000.10.261
[8]
Muresan, M., Olivier, P., Leclère, J., Sirveaux, F., Brunaud, L., Klein, M., et al. (2008) Bone Metastases from Differentiated Thyroid Carcinoma. Endocrine-Related Cancer, 15, 37. https://doi.org/10.1677/ERC-07-0229
[9]
Iñiguez-Ariza, N.M., Bible, K.C. and Clarke, B.L. (2020) Bone Metastases in Thyroid Cancer. Journal of Bone Oncology, 21, Article ID: 100282. https://doi.org/10.1016/j.jbo.2020.100282
[10]
Poon, M., Zeng, L., Zhang., L., Lam, H., Emmenegger, U., Wong, E., et al. (2013) Incidence of Skeletal-Related Events over Time from Solid Tumour Bone Metastases Reported in Randomised Trials Using Bone-Modifying Agents. Clinical Oncology, 25, 435-444. https://doi.org/10.1016/j.clon.2013.03.003
[11]
Farooki, A., Leung, V., Tala, H. and Tuttle, R.M. (2012) Skeletal-Related Events Due to Bone Metastases from Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism, 97, 2433-2439. https://doi.org/10.1210/jc.2012-1169
[12]
Choksi, P., Papaleontiou, M., Guo, C., Worden, F., Banerjee, M. and Haymart, M. (2017) Skeletal Complications and Mortality in Thyroid Cancer: A Population-Based Study. The Journal of Clinical Endocrinology & Metabolism, 102, 1254-1260. https://doi.org/10.1210/jc.2016-3906
[13]
Durante, C., Haddy, N., Baudin, E., Leboulleux, S., Hartl, D., Travagli, J., et al. (2006) Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy. The Journal of Clinical Endocrinology & Metabolism, 91, 2892-2899. https://doi.org/10.1210/jc.2005-2838
[14]
Leboulleux, S., Girard, E., Rose, M., Travagli, J.P., Sabbah, N., Caillou, B., et al. (2007) Ultrasound Criteria of Malignancy for Cervical Lymph Nodes in Patients Followed up for Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism, 92, 3590-3594. https://doi.org/10.1210/jc.2007-0444
[15]
Laufer, I., Rubin, D.G., Lis, E., Cox, B.W., Stubblefield, M.D., Yamada, Y., et al. (2013) The NOMS Framework: Approach to the Treatment of Spinal Metastatic Tumors. The Oncologist, 18, 744-751. https://doi.org/10.1634/theoncologist.2012-0293
